Built to Last: The Infrastructure of Long-Term SOF Resilience

Battelle and The NeuroTech Institute (NTI) launched NeuroLife, a non-invasive neurotechnology company developing wearable solutions to support rehabilitation.

For semiconductor manufacturers, the question is no longer whether PFAS will require greater attention—it’s how quickly companies can understand and manage their exposure. This blog explores why PFAS are essential to semiconductor fabrication, how regulatory and environmental pressures are evolving, and how manufacturers can begin planning their path forward.

In today’s pharma and biotech industries, choosing the right R&D partner is a strategic decision that can shape the trajectory of your entire program. Beyond credentials and case studies, the real differentiator lies in how a partner thinks, collaborates, and evolves. Here's four key questions every leader should ask before hiring a R&D partner.

Special Forces operate at peak intensity for decades—but that performance comes with a cumulative physical and psychological cost. Explore how chronic pain, injury, and allostatic load impact long-term readiness, and why early, integrated, whole-system interventions are essential to sustaining performance, extending careers and improving post-service quality of life.

On May 14 and 15, 2026, Battelle co-sponsored "Beyond Forever: Bridging Policy and Industry with PFAS Solutions," convening policymakers and industry experts at Capitol Hill. We sat down with Battelle's Amy Dindal and Jeff Rose to unpack this important conversation about PFAS policy and solutions.